Opko Health (OPK) Income from Non-Controlling Interests (2012 - 2024)
Opko Health's (OPK) quarterly Income from Non-Controlling Interests came in at $600000.0 in Q1 2024, down 14.29% YoY from $700000.0 in Q2 2023, and down 14.29% on a QoQ basis from $700000.0 in Q4 2023.
Opko Health (OPK) Income from Non-Controlling Interests (2012 - 2024) Analysis & Trends
Opko Health (OPK) has 7 years of Income from Non-Controlling Interests data on file, last reported at $600000.0 in Q1 2024.
- Quarterly Income from Non-Controlling Interests fell 14.29% year-over-year to $600000.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $2.8 million (up 86.67% YoY) and the FY2023 annual result came in at $2.9 million, up 7.41% from the prior year.
- Income from Non-Controlling Interests declined to $600000.0 in Q1 2024, from $700000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $800000.0 in Q3 2023 to a low of $100000.0 in Q3 2022.
- A 3-year average of $614285.7 and a median of $700000.0 in 2022 frame the typical range for Income from Non-Controlling Interests.
- Annual changes were most pronounced in 2023 — Income from Non-Controlling Interests jumped 700.0% — and 2024, when it retreated 14.29%.
- Tracing OPK's Income from Non-Controlling Interests over 3 years: stood at $700000.0 in 2022, then changed by 0.0% to $700000.0 in 2023, then decreased by 14.29% to $600000.0 in 2024.
- The last three Income from Non-Controlling Interests figures came in at $600000.0 (Q1 2024), $700000.0 (Q4 2023), and $800000.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 2.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 400,000.00 |
| 10 | Opko Health | 1.13 Bn | 824.59 Mn | 80.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 600,000.00 |
| Dec 31, 2023 | 700,000.00 |
| Sep 30, 2023 | 800,000.00 |
| Jun 30, 2023 | 700,000.00 |
| Mar 31, 2023 | 700,000.00 |
| Dec 31, 2022 | 700,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2015 | -475,000.00 |
| Mar 31, 2015 | -925,000.00 |
| Dec 31, 2014 | -491,000.00 |
| Sep 30, 2014 | -1.35 Mn |
| Jun 30, 2014 | -597,000.00 |
| Mar 31, 2014 | -540,000.00 |
| Dec 31, 2013 | -630,000.00 |
| Sep 30, 2013 | -803,000.00 |
| Jun 30, 2013 | -959,000.00 |
| Mar 31, 2013 | -547,000.00 |
| Dec 31, 2012 | -492,000.00 |